{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047196","form_type":"8-K","ticker":"NRXS","cik":"0001933567","company_name":"Neuraxis, INC","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.375574+00:00","generated_at":"2026-05-29T21:18:36.326644+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Neuraxis amends Series B Preferred terms: extends dividends, increases authorized shares, revises voting rights","bullets":["Increased authorized Series B Preferred shares from 4,000,000 to 5,000,000.","Extended 8.5% annual dividend right by 18 months, now through December 31, 2026.","Amended voting rights: each Series B share votes equal to common shares convertible at $3.80 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047196","json":"https://secwatch.observer/filing/0001493152-24-047196.json","markdown":"https://secwatch.observer/filing/0001493152-24-047196.md","text":"https://secwatch.observer/filing/0001493152-24-047196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1933567/000149315224047196/0001493152-24-047196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1933567/000149315224047196/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:18:36.326644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}